202 related articles for article (PubMed ID: 32555662)
1. Preliminary study on discriminating HER2 2+ amplification status of breast cancers based on texture features semi-automatically derived from pre-, post-contrast, and subtraction images of DCE-MRI.
Song L; Lu H; Yin J
PLoS One; 2020; 15(6):e0234800. PubMed ID: 32555662
[TBL] [Abstract][Full Text] [Related]
2. The Potential Use of DCE-MRI Texture Analysis to Predict HER2 2+ Status.
Jiang Z; Song L; Lu H; Yin J
Front Oncol; 2019; 9():242. PubMed ID: 31032222
[No Abstract] [Full Text] [Related]
3. Texture Analysis of Breast DCE-MRI Based on Intratumoral Subregions for Predicting HER2 2+ Status.
Lu H; Yin J
Front Oncol; 2020; 10():543. PubMed ID: 32373531
[No Abstract] [Full Text] [Related]
4. Texture Analysis of DCE-MRI Intratumoral Subregions to Identify Benign and Malignant Breast Tumors.
Zhang B; Song L; Yin J
Front Oncol; 2021; 11():688182. PubMed ID: 34307153
[TBL] [Abstract][Full Text] [Related]
5. Performance evaluation of texture analysis based on kinetic parametric maps from breast DCE-MRI in classifying benign from malignant lesions.
Jiang Z; Yin J
J Surg Oncol; 2020 Jun; 121(8):1181-1190. PubMed ID: 32167588
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of texture analysis in determining the gene amplification status of HER2 2+ for invasive ductal carcinoma cases.
Zheng X; Yin J
Minerva Med; 2023 Dec; 114(6):832-838. PubMed ID: 32239879
[TBL] [Abstract][Full Text] [Related]
7. Integration of dynamic contrast-enhanced magnetic resonance imaging and T2-weighted imaging radiomic features by a canonical correlation analysis-based feature fusion method to predict histological grade in ductal breast carcinoma.
Fan M; Liu Z; Xie S; Xu M; Wang S; Gao X; Li L
Phys Med Biol; 2019 Oct; 64(21):215001. PubMed ID: 31470420
[TBL] [Abstract][Full Text] [Related]
8. Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI.
Chang RF; Chen HH; Chang YC; Huang CS; Chen JH; Lo CM
Magn Reson Imaging; 2016 Jul; 34(6):809-819. PubMed ID: 26968141
[TBL] [Abstract][Full Text] [Related]
9. Texture Analysis Using Semiquantitative Kinetic Parameter Maps from DCE-MRI: Preoperative Prediction of HER2 Status in Breast Cancer.
Song L; Li C; Yin J
Front Oncol; 2021; 11():675160. PubMed ID: 34168994
[TBL] [Abstract][Full Text] [Related]
10. Robustness of radiomic features of benign breast lesions and hormone receptor positive/HER2-negative cancers across DCE-MR magnet strengths.
Whitney HM; Drukker K; Edwards A; Papaioannou J; Medved M; Karczmar G; Giger ML
Magn Reson Imaging; 2021 Oct; 82():111-121. PubMed ID: 34174331
[TBL] [Abstract][Full Text] [Related]
11. Characterization of spatiotemporal changes for the classification of dynamic contrast-enhanced magnetic-resonance breast lesions.
Milenković J; Hertl K; Košir A; Zibert J; Tasič JF
Artif Intell Med; 2013 Jun; 58(2):101-14. PubMed ID: 23548472
[TBL] [Abstract][Full Text] [Related]
12. Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set.
Cain EH; Saha A; Harowicz MR; Marks JR; Marcom PK; Mazurowski MA
Breast Cancer Res Treat; 2019 Jan; 173(2):455-463. PubMed ID: 30328048
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
Braman NM; Etesami M; Prasanna P; Dubchuk C; Gilmore H; Tiwari P; Plecha D; Madabhushi A
Breast Cancer Res; 2017 May; 19(1):57. PubMed ID: 28521821
[TBL] [Abstract][Full Text] [Related]
14. Preoperative prediction of sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast-enhanced MRI.
Liu C; Ding J; Spuhler K; Gao Y; Serrano Sosa M; Moriarty M; Hussain S; He X; Liang C; Huang C
J Magn Reson Imaging; 2019 Jan; 49(1):131-140. PubMed ID: 30171822
[TBL] [Abstract][Full Text] [Related]
15. MRI texture features differentiate clinicopathological characteristics of cervical carcinoma.
Wang M; Perucho JAU; Tse KY; Chu MMY; Ip P; Lee EYP
Eur Radiol; 2020 Oct; 30(10):5384-5391. PubMed ID: 32382845
[TBL] [Abstract][Full Text] [Related]
16. Multi-parametric MRI lesion heterogeneity biomarkers for breast cancer diagnosis.
Tsarouchi MI; Vlachopoulos GF; Karahaliou AN; Vassiou KG; Costaridou LI
Phys Med; 2020 Dec; 80():101-110. PubMed ID: 33137621
[TBL] [Abstract][Full Text] [Related]
17. Prediction of prostate cancer aggressiveness with a combination of radiomics and machine learning-based analysis of dynamic contrast-enhanced MRI.
Liu B; Cheng J; Guo DJ; He XJ; Luo YD; Zeng Y; Li CM
Clin Radiol; 2019 Nov; 74(11):896.e1-896.e8. PubMed ID: 31495546
[TBL] [Abstract][Full Text] [Related]
18. Computer-based automated estimation of breast vascularity and correlation with breast cancer in DCE-MRI images.
Kostopoulos SA; Vassiou KG; Lavdas EN; Cavouras DA; Kalatzis IK; Asvestas PA; Arvanitis DL; Fezoulidis IV; Glotsos DT
Magn Reson Imaging; 2017 Jan; 35():39-45. PubMed ID: 27569368
[TBL] [Abstract][Full Text] [Related]
19. Radiomics Signatures Based on Multiparametric MRI for the Preoperative Prediction of the HER2 Status of Patients with Breast Cancer.
Zhou J; Tan H; Li W; Liu Z; Wu Y; Bai Y; Fu F; Jia X; Feng A; Liu H; Wang M
Acad Radiol; 2021 Oct; 28(10):1352-1360. PubMed ID: 32709582
[TBL] [Abstract][Full Text] [Related]
20. Computerized image analysis for identifying triple-negative breast cancers and differentiating them from other molecular subtypes of breast cancer on dynamic contrast-enhanced MR images: a feasibility study.
Agner SC; Rosen MA; Englander S; Tomaszewski JE; Feldman MD; Zhang P; Mies C; Schnall MD; Madabhushi A
Radiology; 2014 Jul; 272(1):91-9. PubMed ID: 24620909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
